The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Surgery for patients receiving ipilimumab: Safety profile and immunological insights.
David E. Gyorki
No relevant relationships to disclose
Jianda Yuan
No relevant relationships to disclose
Zhenyu Mu
No relevant relationships to disclose
Bushra Zaidi
No relevant relationships to disclose
Humilidad F. Gallardo
No relevant relationships to disclose
Mary Susan Brady
Consultant or Advisory Role - Amgen
Philip H. Gutin
No relevant relationships to disclose
Daniel G. Coit
No relevant relationships to disclose
Jedd D. Wolchok
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Charlotte Eielson Ariyan
No relevant relationships to disclose